Deciphera Pharmaceuticals

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch DCPH and buy or sell other stocks, ETFs, and their options commission-free!

About DCPH

Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing important new medicines to improve the lives of people with cancer. We are leveraging our proprietary switch-control kinase inhibitor platform and deep expertise in kinase biology to develop a broad portfolio of innovative medicines. 

CEO
Ryota Udagawa
CEORyota Udagawa
Employees
—
Employees—
Headquarters
Waltham, Massachusetts
HeadquartersWaltham, Massachusetts
Founded
2003
Founded2003
Employees
—
Employees—

DCPH Key Statistics

Market cap
2.10B
Market cap2.10B
Price-Earnings ratio
-11.58
Price-Earnings ratio-11.58
Dividend yield
—
Dividend yield—
Average volume
—
Average volume—
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$25.61
52 Week high$25.61
52 Week low
$9.90
52 Week low$9.90
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.